These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11508275)

  • 1. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.
    Sima AA; Zhang W; Sugimoto K; Henry D; Li Z; Wahren J; Grunberger G
    Diabetologia; 2001 Jul; 44(7):889-97. PubMed ID: 11508275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats.
    Zhang W; Kamiya H; Ekberg K; Wahren J; Sima AA
    Diabetes Metab Res Rev; 2007 Jan; 23(1):63-70. PubMed ID: 16845685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.
    Stevens MJ; Zhang W; Li F; Sima AA
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E497-505. PubMed ID: 15126237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats.
    Sima AA; Zhang W; Xu G; Sugimoto K; Guberski D; Yorek MA
    Diabetologia; 2000 Jun; 43(6):786-93. PubMed ID: 10907124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes.
    Kamiya H; Zhang W; Sima AA
    Ann Neurol; 2004 Dec; 56(6):827-35. PubMed ID: 15497155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.
    Kamiya H; Murakawa Y; Zhang W; Sima AA
    Diabetes Metab Res Rev; 2005; 21(5):448-58. PubMed ID: 15747389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
    Kamiya H; Zhang W; Ekberg K; Wahren J; Sima AA
    Diabetes; 2006 Dec; 55(12):3581-7. PubMed ID: 17130507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.
    Pierson CR; Zhang W; Sima AA
    J Neuropathol Exp Neurol; 2003 Jul; 62(7):765-79. PubMed ID: 12901702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetic neuropathy and C-peptide.
    Sima AA; Zhang W; Grunberger G
    Exp Diabesity Res; 2004; 5(1):65-77. PubMed ID: 15198372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.
    Zhang W; Yorek M; Pierson CR; Murakawa Y; Breidenbach A; Sima AA
    Int J Exp Diabetes Res; 2001; 2(3):187-93. PubMed ID: 12369706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities.
    Sima AA; Brismar T
    Ann Neurol; 1985 Jul; 18(1):21-9. PubMed ID: 3898998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy.
    Pierson CR; Zhang W; Murakawa Y; Sima AA
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):260-71. PubMed ID: 12638730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide.
    Sima AA; Zhang W; Li ZG; Murakawa Y; Pierson CR
    Diabetes; 2004 Jun; 53(6):1556-63. PubMed ID: 15161761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
    Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
    Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats.
    Jamali R; Mohseni S
    Acta Neuropathol; 2005 Feb; 109(2):198-206. PubMed ID: 15549329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.
    Sima AA; Zhang W; Li ZG; Kamiya H
    Exp Diabetes Res; 2008; 2008():230458. PubMed ID: 18437223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats.
    Zhang W; Slusher B; Murakawa Y; Wozniak KM; Tsukamoto T; Jackson PF; Sima AA
    J Neurol Sci; 2002 Feb; 194(1):21-8. PubMed ID: 11809162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat.
    Kappelle AC; Biessels G; Bravenboer B; van Buren T; Traber J; de Wildt DJ; Gispen WH
    Br J Pharmacol; 1994 Mar; 111(3):887-93. PubMed ID: 8019766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac function and ischaemic tolerance during acute loss of metabolic control in the diabetic BB Wor rat.
    Broderick TL; Poirier P
    Acta Diabetol; 2005 Dec; 42(4):171-8. PubMed ID: 16382304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.